Quickly Generate High-Diversity, High-
Quality Molecules Inspired by the Human
Repertoire
Best-In-Class Synthetic Libraries Powered by Twist Technology
We are writing the future of biologics discovery with a best-in-class platform, our Library of Libraries, for hard-to-drug targets. Our collection of 17+ off-the-shelf libraries enables multiple pathways of discovery for your drug target of interest. We use our precision DNA synthesis technology to focus explicitly on the sequence space that will most benefit you and remove sequences associated with downstream developability and manufacturing liabilities.
Stöbern Sie durch unsere Library of Libraries
scFv Library Series
Hyperimmune Libraries
Einzeldomänen-Libraries
GPCR-Libraries
Quickly Generate High-Diversity, High-
Quality Molecules Inspired by the Human
Repertoire
Best-In-Class Synthetic Libraries Powered by Twist Technology
We are writing the future of biologics discovery with a best-in-class platform, our Library of Libraries, for hard-to-drug targets. Our collection of 17+ off-the-shelf libraries enables multiple pathways of discovery for your drug target of interest. We use our precision DNA synthesis technology to focus explicitly on the sequence space that will most benefit you and remove sequences associated with downstream developability and manufacturing liabilities.
Stöbern Sie durch unsere Library of Libraries
scFv Library Series
Hyperimmune Libraries
Einzeldomänen-Libraries
GPCR-Libraries
Uncover Hits Against Virtually Any Target
Erweitern Sie Ihre Identifizierungsmöglichkeiten
Unsere vorab zusammengestellten und validierten Phagen-Display-Librarys werden mithilfe unserer präzisen DNA-Schreibtechnologie erstellt. Damit können wir Motive entfernen, die zu nachgelagerten die Fertigung hemmenden Faktoren führen können, und den Fokus ausschließlich auf den jeweiligen Sequenzabschnitt legen. Twist Bioscience has designed multiple general, naïve, and target-focused libraries with diversities of 1010, giving you a multifaceted approach to your next discovery project.
Fast Antibody Discovery
Our collection of off-the-shelf libraries enables you to quickly identify high-quality leads against your target of interest using multiple strategies in only a few months. Libraries are available in various VHH, Fab, and scFv formats. These libraries can be leveraged to develop monoclonal antibodies, bi- or multi-specifics, and chimeric antigen receptors (CARs) for CAR-T cell therapy.
A Proven Discovery Engine
Internal discovery efforts using the library of libraries have led to the generation and optimization of lead antibody agonists, antagonists, and binders, with robust pre-clinical data packages. Our fully-humanized antibodies and VHH nanobodies are available for licensing. They make it possible to drug high-value targets in broad therapeutic areas, including immuno-oncology, oncology, metabolic diseases, and more.
Uncover Hits Against Virtually Any Target
Erweitern Sie Ihre Identifizierungsmöglichkeiten
Unsere vorab zusammengestellten und validierten Phagen-Display-Librarys werden mithilfe unserer präzisen DNA-Schreibtechnologie erstellt. Damit können wir Motive entfernen, die zu nachgelagerten die Fertigung hemmenden Faktoren führen können, und den Fokus ausschließlich auf den jeweiligen Sequenzabschnitt legen. Twist Bioscience has designed multiple general, naïve, and target-focused libraries with diversities of 1010, giving you a multifaceted approach to your next discovery project.
Fast Antibody Discovery
Our collection of off-the-shelf libraries enables you to quickly identify high-quality leads against your target of interest using multiple strategies in only a few months. Libraries are available in various VHH, Fab, and scFv formats. These libraries can be leveraged to develop monoclonal antibodies, bi- or multi-specifics, and chimeric antigen receptors (CARs) for CAR-T cell therapy.
A Proven Discovery Engine
Internal discovery efforts using the library of libraries have led to the generation and optimization of lead antibody agonists, antagonists, and binders, with robust pre-clinical data packages. Our fully-humanized antibodies and VHH nanobodies are available for licensing. They make it possible to drug high-value targets in broad therapeutic areas, including immuno-oncology, oncology, metabolic diseases, and more.
Produktblatt
Webinar
Poster
Kontakt
Antikörper-Enthusiasten stehen bereit und würden gerne mehr über Ihren Forschungsbedarf erfahren. Wir begrüßen schwierige Targets!
